Literature DB >> 7502528

The consequences of hypergastrinemia.

W Creutzfeldt1.   

Abstract

The only gastrin-dependent gastric endocrine cells are the fundic ECL cells. Excessive hypergastrinemia stimulates ECL cell proliferation in animals and man. The growth of other gastric endocrine cells is regulated by the gastric pH. Hypergastrinemia in man results in diffuse and linear hyperplasia of the ECL cells, while micronodular hyperplasia is correlated to the grade of corpus gastritis. ECL cell dysplasia and gastric carcinoids in man have been observed only in patients with gastrinoma as part of the MEN I syndrome and with pernicious anemia. Gastrin dependence of GI adenocarcinoma has not been established. Experimental findings may be explained by the presence of gastrin receptors and the role of gastrin as an autocrine growth factor. Epidemiological data do not support gastrin dependence of carcinoma of the stomach, the pancreas and the colon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7502528      PMCID: PMC2588917     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  60 in total

Review 1.  The achlorhydria-carcinoid sequence: role of gastrin.

Authors:  W Creutzfeldt
Journal:  Digestion       Date:  1988       Impact factor: 3.216

2.  Serum levels of gastrin in patients with colorectal neoplasia.

Authors:  H Suzuki; K Matsumoto; H Terashima
Journal:  Dis Colon Rectum       Date:  1988-09       Impact factor: 4.585

3.  Cancer after peptic ulcer surgery.

Authors:  D C Carter
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

4.  A silver nitrate stain for alpha-2 cells in human pancreatic islets.

Authors:  L Grimelius
Journal:  Acta Soc Med Ups       Date:  1968

5.  Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations.

Authors:  M Siurala; J Lehtola; T Ihamäki
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

Review 6.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

Authors:  J Penston; K G Wormsley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

7.  Mortality from gastric cancer following gastric surgery for peptic ulcer.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

8.  Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.

Authors:  N Havu
Journal:  Digestion       Date:  1986       Impact factor: 3.216

9.  Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.

Authors:  R Lamberts; W Creutzfeldt; F Stöckmann; U Jacubaschke; S Maas; G Brunner
Journal:  Digestion       Date:  1988       Impact factor: 3.216

10.  Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat.

Authors:  M Chu; L Franzén; S Sullivan; S Wingren; J F Rehfeld; K Borch
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

View more
  5 in total

1.  Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.

Authors:  J J Meier; A E Butler; R Galasso; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2006-09-23       Impact factor: 10.122

2.  Constitutive achlorhydria in mucolipidosis type IV.

Authors:  R Schiffmann; N K Dwyer; I A Lubensky; M Tsokos; V E Sutliff; J S Latimer; K P Frei; R O Brady; N W Barton; E J Blanchette-Mackie; E Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 3.  Clinical aspects of ECL-cell abnormalities.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 4.  Hypergastrinemia.

Authors:  Sunil Dacha; Mohammed Razvi; Julia Massaad; Qiang Cai; Mohammad Wehbi
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-18

Review 5.  Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells.

Authors:  Helge Waldum; Patricia Mjønes
Journal:  Cancers (Basel)       Date:  2020-11-22       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.